Yves Bikorimana: Before Wash vs After Wash in Blood Grouping
Yves Bikorimana, CEO at MedData-Rwanda and Lab Scientist at The University Teaching Hospital of Kigali-Chuk, shared a post on LinkedIn:
“Before Wash vs After Wash in Blood Grouping – Why It Matters
In immunohematology, small technical details can completely change interpretation. This image perfectly demonstrates the importance of the saline wash step during blood grouping and antibody testing.
Let’s break it down
Left Side: Tube Method (Cell Washing)
Before Wash
We see a red cell suspension with plasma and possible interfering substances still present. Proteins, rouleaux formation, or excess antibodies can create pseudo-agglutination or mask true reactions.
After 3× Saline Wash plus Centrifugation
The supernatant becomes clear, and only packed red cells remain at the bottom.
Why is this important?
- Removes unbound antibodies
- Eliminates excess plasma proteins
- Prevents false reactions
- Improves accuracy of antiglobulin testing
Washing ensures we are detecting true antigen–antibody reactions, not artifacts.
Right Side: Slide/Card Agglutination (Anti-A, Anti-B, Anti-D)
Before Wash
Anti-D appears weakly positive — but note the label: False agglutination.
Sometimes:
- Rouleaux formation
- Fibrin strands
- High protein states
- Improper cell suspension
can mimic agglutination.
After Wash
The false Anti-D reaction disappears.
Result interpretation becomes clear and reliable.
- Anti-A: Negative
- Anti-B: Negative
- Anti-D: Negative
Final Blood Group: O Rh(D) Negative
Key Takeaway
In transfusion medicine, accuracy is patient safety.
A simple saline wash step can:
- Prevent mislabeling of blood groups
- Avoid incompatible transfusions
- Reduce risk of hemolytic transfusion reactions
In laboratory science, precision isn’t optional — it’s ethical responsibility.”

Stay updated with Hemostasis Today.
-
Jul 14, 2026, 19:35Daratumumab in Difficult-to-Treat iTTP: Updated Results from the International DarTTP Study
-
Jul 14, 2026, 17:1610 Posts Not To Miss from ISTH 2026, Part 3
-
Jul 14, 2026, 15:27Dianne E Van Der Wal: Celebrating Scientific Contributions at ISTH 2026
-
Jul 14, 2026, 15:13Alfonso Tafur: RIETE Registry Analysis Supports More Equitable Approaches to VTE Care
-
Jul 14, 2026, 15:03Heghine Khachatryan: Phase III Trial Results Support BAFF-R Inhibition in Corticosteroid-Refractory ITP
-
Jul 14, 2026, 14:51Nathan Connell: ISTH 2026 Highlights the Power of Lifelong Collaboration
-
Jul 14, 2026, 14:42Wolfgang Miesbach: VOYAGER1 Highlights Progress Toward Injection-Free Care in Hemophilia A
-
Jul 14, 2026, 12:08Elvira Grandone: Finding the Right LMWH Dose for Pregnant Patients Suffering From DVT
-
Jul 14, 2026, 12:05Eloïse Laouenan: From Washington to Paris – Join GETBO at ISTH 2026